Related Experiment Video
Updated: Oct 4, 2025

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
MMP-9 secreted by M2-type macrophages promotes Wilms' tumour metastasis through the PI3K/AKT pathway
Kaixuan Tian1,2, Guoqiang Du2, Xiaoqing Wang2
1Department of Pediatric Orthopaedics, The Third Hospital of Hebei Medical University, Shijiazhuang, 050051, Hebei, People's Republic of China.
Background:
Wilms' tumour (WT) is a malignant tumour of childhood with the typical symptoms of an abdominal mass. Tumour-associated macrophages (TAMs) accumulate and imply a poor prognosis in WT, but the mechanism of how TAMs affect the prognosis has not been fully elucidated. In this study, we aimed to present the molecular mechanisms underlying the protumorigenic capacities of TAMs in WT.
Methods:
TAMs were polarized into M1- and M2-type macrophages. The two types of macrophages were cocultured with SK-NEP-1 cells, and their cell viability and invasion ability were measured. Matrix metalloproteinase 9 (MMP9) expression was assessed in different types of macrophages, and the role of MMP9 in WT was explored. Then data from children diagnosed with WT in our department between February 2006 and July 2014 were retrospectively analysed, the tumour tissues were analysed to explore the distribution of MMP9. Kaplan-Meier analysis of the relationship between MMP9 expression and follow-up information was performed.
Results:
The results showed that M2-type macrophages could improve the viability and invasive ability of SK-NEP-1 cells. MMP9 expression in M2-type macrophages was significantly higher than that in M1-type macrophages. MMP9 could activate the AKT/PI3K signalling pathway to initiate the epithelial-mesenchymal transition (EMT) process, and promote the proliferation and invasion of WT. In WT tissue, the MMP9 expression level was elevated and it was located in the tumour stroma, which was the same as M2-type macrophage location, and a high level of MMP9 predicted poor survival.
Conclusion:
M2-type macrophages facilitate tumour proliferation and metastasis by secreting MMP9 to enhance the EMT process via a PI3K/AKT dependent pathway in Wilms' tumour.
Insights
M2 macrophages promote Wilms' tumour growth and spread by releasing MMP9, which drives epithelial-mesenchymal transition via the PI3K/AKT pathway. High MMP9 levels in tumour tissue indicate a poor prognosis for childhood cancer patients.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Wilms' tumour (WT) is a common childhood kidney cancer.
- Tumour-associated macrophages (TAMs) are linked to poor prognosis in WT, but their exact role is unclear.
- Understanding TAMs' protumorigenic mechanisms is crucial for improving WT treatment.
Purpose of the Study:
- To elucidate the molecular mechanisms by which TAMs promote Wilms' tumour progression.
- To investigate the role of Matrix metalloproteinase 9 (MMP9) in TAM-mediated WT growth and metastasis.
Main Methods:
- Polarization of TAMs into M1 and M2 subtypes and co-culture with WT cells.
- Assessment of cell viability, invasion, and MMP9 expression.
- Analysis of MMP9 distribution in WT tissues and correlation with patient survival data.
Main Results:
- M2 macrophages significantly enhanced WT cell viability and invasion compared to M1 macrophages.
- M2 macrophages exhibited higher MMP9 expression, which was elevated in WT tissues.
- MMP9 activated the PI3K/AKT pathway, promoting epithelial-mesenchymal transition (EMT), proliferation, and invasion in WT.
- High MMP9 expression correlated with poor patient survival.
Conclusions:
- M2-type TAMs promote Wilms' tumour proliferation and metastasis.
- This occurs via MMP9 secretion, which enhances EMT through the PI3K/AKT pathway.
- MMP9 serves as a potential biomarker for poor prognosis in Wilms' tumour.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Role of Matrix Metalloproteases in Degradation of ECM
The Tumor Microenvironment
Canonical Wnt Signaling Pathway

